Literature DB >> 9021527

Quantitation of soluble E-receptor of T lymphocytes in serum from HIV-1 positive patients.

G Nuñez1, N C Moura, H J Hernandez, Z F Peixinho, R S Zeballos, N Cavalcante, P Flores, I M Longo, N F Mendes.   

Abstract

Human T lymphocytes carry a membrane receptor for sheep erythrocytes (E) related to the CD2 molecule. The E-receptor is found in a soluble from (Rs) in serum and can be quantitated by "rocket electrophoresis" using an anti-Rs serum obtained by immunizing sheep with autologous erythrocytes coated with Rs. Increased serum levels of Rs are found in patients with diseases associated with immunodepression. In the present study, 14 asymptomatic HIV-1 seropositive individuals were investigated regarding their Rs levels and delayed hypersensitivity skin tests every 3 months for a period of 35 months. All these patients progressed to AIDS in this period. Rs serum levels have also been quantitated in 14 normal individuals. The mean Rs values in normal individuals, asymptomatic, and AIDS patients were, respectively: 4.8 +/- 1.5 mm (SD), 9.6 +/- 1.9 mm (SD) and 11.3 +/- 2.4 mm (SD). An increase of Rs serum levels was observed when we compared normal individuals with CDC-II and CDC-IV clinical stage patients (P < 0.05, Mann-Whitney test) and CDC-II and CDC-IV patients, (P < 0.05, Wilcoxon test). We have observed a depressed delayed hypersensitivity response to ubiquitous antigens in CDC-IV patients. Our results indicate that Rs serum levels can be used as a progression marker in HIV infected patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021527      PMCID: PMC6760723          DOI: 10.1002/(sici)1098-2825(1997)11:1<69::aid-jcla11>3.0.co;2-n

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  29 in total

1.  Immunosuppressive effect of soluble E receptors in uremic serum.

Authors:  C C Musatti; V A Soares; L M Santos; J J De Lima; N F Mendes
Journal:  Clin Immunol Immunopathol       Date:  1979-12

2.  Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes.

Authors:  N F Mendes; P J Saraiva; O B Santos
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

3.  Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation.

Authors:  A Bernard; H C Tran; L Boumsell
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

4.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

5.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

6.  Molecular forms of soluble human T lymphocyte receptor for sheep erythrocytes in serum and saliva.

Authors:  E N Itano; M A Ono; M Sumigawa; I M Longo; N C Moura; N F Mendes
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

7.  Purification of soluble human T lymphocyte receptors for sheep erythrocytes.

Authors:  E N Itano; M A Ono; M Sumigawa; I M Longo; N C Moura; N F Mendes
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

8.  Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors".

Authors:  W Verbi; M F Greaves; C Schneider; K Koubek; G Janossy; H Stein; P Kung; G Goldstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

9.  Quantification of the soluble receptor of human T lymphocytes for sheep erythrocytes in the serum of patients with aplastic anaemia.

Authors:  R P Falcão; I M Longo; N C Moura; N F Mendes
Journal:  J Clin Lab Immunol       Date:  1984-03

10.  Quantitation of the soluble receptor of human T lymphocytes for sheep erythrocytes by electroimmunodiffusion in the serum of patients with cancer, uremia and leprosy.

Authors:  N C Moura; I M Longo; L A Bernd; N F Mendes
Journal:  Experientia       Date:  1983-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.